Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Cardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic ConsiderationsNonatherosclerotic Cardiovascular Disease in Chronic Kidney Disease
Sex Differences in Cardiovascular Diseases and Vascular Function in Chronic Kidney Disease
Obesity and Cardiovascular-Kidney-Metabolic Health: Ethnicity-Based Risk and Clinical Considerations
Sodium Glucose Cotransporter 2 Inhibitors Across the Spectrum of Cardiovascular Kidney Metabolic Syndrome
Role of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/ Glucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) Conditions
Atherosclerotic Cardiovascular Disease in Cardiovascular-Kidney-Metabolic Syndrome
Kidney Transplant and Cardiovascular-Kidney-Metabolic Health
Long-Term Cardio-Renal-Metabolic Complications Following Pre-eclampsia
A Plant-Based Diet for Cardiovascular Risk Reduction in Kidney Disease with a Focus on Cardiovascular-Kidney-Metabolic Syndrome
Cardio-Kidney Metabolic Health in Pediatrics and Primordial Prevention
History and Evolution of Hypertension Goals in Patients with Chronic Kidney Disease

